X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (468) 468
oncology (387) 387
female (340) 340
recursive partitioning analysis (336) 336
index medicus (331) 331
middle aged (326) 326
male (320) 320
aged (317) 317
radiotherapy (295) 295
radiation-therapy (287) 287
brain neoplasms - secondary (272) 272
adult (252) 252
surgery (232) 232
prognosis (215) 215
partitioning analysis rpa (205) 205
survival (199) 199
radiosurgery (191) 191
brain metastases (189) 189
metastasis (189) 189
stereotactic radiosurgery (187) 187
prognostic-factors (186) 186
brain neoplasms - surgery (184) 184
retrospective studies (181) 181
brain neoplasms - radiotherapy (173) 173
clinical neurology (170) 170
brain neoplasms - mortality (167) 167
treatment outcome (150) 150
aged, 80 and over (149) 149
care and treatment (137) 137
chemotherapy (122) 122
cancer (121) 121
radiology, nuclear medicine & medical imaging (119) 119
randomized-trial (115) 115
combined modality therapy (112) 112
survival analysis (112) 112
analysis (103) 103
radiation (95) 95
karnofsky performance status (93) 93
medicine & public health (91) 91
management (88) 88
survival rate (86) 86
radiation therapy (85) 85
cerebral metastases (81) 81
brain neoplasms - therapy (79) 79
radiosurgery - methods (74) 74
multivariate analysis (72) 72
glioblastoma (70) 70
hematology, oncology and palliative medicine (69) 69
kaplan-meier estimate (69) 69
follow-up studies (68) 68
glioblastoma multiforme (68) 68
brain (67) 67
prognostic factors (64) 64
single metastases (64) 64
research (63) 63
brain metastasis (61) 61
cell lung-cancer (61) 61
lung neoplasms - pathology (61) 61
metastases (61) 61
gamma-knife radiosurgery (60) 60
therapy-oncology-group (60) 60
tumors (60) 60
patient outcomes (58) 58
temozolomide (57) 57
neurology (56) 56
disease-free survival (54) 54
carcinoma (53) 53
brain neoplasms - pathology (52) 52
trial (52) 52
young adult (52) 52
brain neoplasms - drug therapy (51) 51
cranial irradiation (51) 51
patients (50) 50
analysis rpa (49) 49
brain cancer (49) 49
glioblastoma - mortality (48) 48
malignant glioma (48) 48
radiotherapy dosage (47) 47
newly-diagnosed glioblastoma (46) 46
proportional hazards models (46) 46
brain tumors (44) 44
glioblastoma - radiotherapy (44) 44
cranial irradiation - methods (43) 43
radiology (42) 42
neurosurgery (40) 40
risk factors (40) 40
whole-brain radiotherapy (40) 40
adolescent (39) 39
glioblastoma - surgery (39) 39
surgical resection (39) 39
toxicity (39) 39
magnetic resonance imaging (37) 37
quality of life (36) 36
gamma knife (35) 35
health aspects (35) 35
medical prognosis (35) 35
phase-ii (35) 35
resection (35) 35
adjuvant temozolomide (34) 34
breast neoplasms - pathology (34) 34
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (577) 577
French (6) 6
German (4) 4
Spanish (3) 3
Italian (1) 1
Japanese (1) 1
Polish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2011, Volume 81, Issue 3, pp. 623 - 630
Purpose Previous recursive partitioning analysis (RPA) of patients with malignant glioma (glioblastoma multiforme [GBM] and anaplastic astrocytoma [AA])... 
Radiology | Hematology, Oncology and Palliative Medicine | Recursive partitioning analysis | RTOG | Prognostic factors | Glioblastoma | POSTOPERATIVE TREATMENT | PROGNOSTIC-FACTORS | HYPERFRACTIONATED RADIOTHERAPY | NEWLY-DIAGNOSED GLIOBLASTOMA | PHASE-II | RANDOMIZED-TRIAL | ADJUVANT TEMOZOLOMIDE | MALIGNANT GLIOMA | ONCOLOGY | SURVIVAL-DATA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | HIGH-GRADE GLIOMA | Multivariate Analysis | Prognosis | Age Factors | Humans | Middle Aged | Glioblastoma - psychology | Young Adult | Carmustine - therapeutic use | Karnofsky Performance Status | Aged, 80 and over | Adult | Glioblastoma - classification | Brain Neoplasms - mortality | Radiotherapy Dosage | Brain Neoplasms - psychology | Databases, Factual - statistics & numerical data | Clinical Trials as Topic | Models, Statistical | Antineoplastic Agents, Alkylating - therapeutic use | Glioblastoma - therapy | Brain Neoplasms - classification | Brain Neoplasms - therapy | Aged | Decision Trees | Glioblastoma - mortality | Radiotherapy | Glioblastoma multiforme | Analysis | Radiation | GLIOMAS | NEOPLASMS | PERFORMANCE | VALIDATION | RADIATION DOSES | MEDICINE | NUCLEAR MEDICINE | NERVOUS SYSTEM DISEASES | TESTING | DISEASES | THERAPY | DOSES | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | RADIOLOGY | recursive partitioning analysis | prognostic factors
Journal Article
World Neurosurgery, ISSN 1878-8750, 07/2019, Volume 127, pp. e124 - e131
Accurate survival estimate is necessary when determining the most appropriate treatment modality for metastatic spinal tumor. The main purpose of this study... 
Prognostic factor | Spinal metastasis | Recursive partitioning analysis | Survival | Decision tree model | SURGERY | TOKUHASHI SCORE | CORD COMPRESSION | PREOPERATIVE EVALUATION | RADIOTHERAPY | CLINICAL NEUROLOGY | Care and treatment | Prognosis | Metastasis | Patient outcomes | Analysis
Journal Article
Lancet, The, ISSN 0140-6736, 2016, Volume 388, Issue 10055, pp. 2004 - 2014
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 77, Issue 3, pp. 655 - 661
Purpose Controversy endures regarding the optimal treatment of patients with brain metastases (BMs). Debate persists, despite many randomized trials, perhaps... 
Radiology | Hematology, Oncology and Palliative Medicine | radiotherapy | Brain metastases | prognosis | stereotactic radiosurgery | COST-EFFECTIVENESS | PARTITIONING ANALYSIS RPA | RADIATION-THERAPY | TRIAL | ONCOLOGY | NEUROCOGNITIVE FUNCTION | RANDOMIZED PHASE-III | ACCELERATED-FRACTIONATION | SINGLE METASTASES | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Carcinoma, Non-Small-Cell Lung - radiotherapy | Gastrointestinal Neoplasms | Prognosis | Age Factors | Humans | Middle Aged | Lung Neoplasms | Small Cell Lung Carcinoma - drug therapy | Small Cell Lung Carcinoma - secondary | Brain Neoplasms - secondary | Carcinoma, Non-Small-Cell Lung - secondary | Karnofsky Performance Status | Small Cell Lung Carcinoma - radiotherapy | Retrospective Studies | Brain Neoplasms - radiotherapy | Carcinoma, Renal Cell - drug therapy | Kidney Neoplasms | Brain Neoplasms - diagnosis | Melanoma - radiotherapy | Treatment Outcome | Brain Neoplasms - drug therapy | Melanoma - secondary | Carcinoma, Renal Cell - radiotherapy | Analysis of Variance | Carcinoma, Renal Cell - secondary | Melanoma - drug therapy | Skin Neoplasms | Selection Bias | Aged | Combined Modality Therapy - methods | Carcinoma, Non-Small-Cell Lung - drug therapy | Care and treatment | Metastasis | Patient outcomes | Analysis | SURGERY | METASTASES | NERVOUS SYSTEM | CENTRAL NERVOUS SYSTEM | MEDICINE | NUCLEAR MEDICINE | ORGANS | THERAPY | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | BODY | BRAIN | RADIOLOGY
Journal Article
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, ISSN 0360-3016, 11/2016, Volume 96, Issue 4, pp. 921 - 922
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2012, Volume 82, Issue 5, pp. 2111 - 2117
Purpose The diagnosis-specific Graded Prognostic Assessment (GPA) was published to clarify prognosis for patients with brain metastases. This study refines the... 
Radiology | Hematology, Oncology and Palliative Medicine | Stereotactic radiosurgery | Prognosis | Estrogen | Breast cancer | Brain metastases | Radiation therapy | Progesterone | HER2 | Outcomes | ADJUVANT CHEMOTHERAPY | PARTITIONING ANALYSIS RPA | CEREBRAL METASTASES | ESTROGEN-RECEPTOR | DISTANT RECURRENCE | NERVOUS-SYSTEM METASTASES | ONCOLOGY | RANDOMIZED PHASE-III | RADIOTHERAPY | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Multivariate Analysis | Receptors, Estrogen - metabolism | Age Factors | Humans | Middle Aged | Brain Neoplasms - pathology | Receptor, ErbB-2 - metabolism | Male | Breast Neoplasms, Male - mortality | Breast Neoplasms - metabolism | Receptors, Progesterone - metabolism | Brain Neoplasms - secondary | Karnofsky Performance Status | Aged, 80 and over | Adult | Female | Retrospective Studies | Brain Neoplasms - mortality | Proportional Hazards Models | Breast Neoplasms, Male - metabolism | Breast Neoplasms - pathology | Breast Neoplasms - mortality | Aged | Breast Neoplasms, Male - pathology | Cohort Studies | CT imaging | Medical colleges | Care and treatment | Patient outcomes | Radiation | Metastasis | Biometry | Cancer patients | Nuclear radiation | Analysis | Public health | Tumors | Brain | Databases | Decision making | Clinical trials | Data processing | ErbB-2 protein | Survival | Age | Metastases | ESTROGENS | SURGERY | DIAGNOSIS | PATIENTS | MAMMARY GLANDS | NEOPLASMS | PROGESTERONE | CLINICAL TRIALS | METASTASES | MULTIVARIATE ANALYSIS | SURVIVAL TIME | DECISION MAKING | RADIOLOGY AND NUCLEAR MEDICINE | BRAIN | estrogen | outcomes | brain metastases | radiation therapy | progesterone | breast cancer | prognosis | stereotactic radiosurgery
Journal Article
Acta Oncologica, ISSN 0284-186X, 02/2018, Volume 57, Issue 2, pp. 231 - 238
Background: Whole-brain radiotherapy (WBRT) has been the standard of care for multiple NSCLC brain metastases but due to its toxicity and lack of survival... 
SYSTEM | MANAGEMENT | SCORE | STEREOTACTIC RADIOSURGERY | ONCOLOGY | PARTITIONING ANALYSIS RPA | MUTATIONS | HISTOLOGY | ELDERLY-PATIENTS | CHEMOTHERAPY | RADIATION-THERAPY | Index Medicus
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 04/2015, Volume 21, Issue 8, pp. 1896 - 1903
Journal Article